{
  "id": 7539097,
  "title": "Augurex Announces Mayo Clinic Laboratories Now Offering 14-3-3eta Testing for Rheumatoid Arthritis",
  "url": "https://urgent.news/2026/09/15/augurex-announces-mayo-clinic-laboratories-now-offering-14-3-3eta",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-15T11:12:19.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/augurex-announces-mayo-clinic-laboratories-now-offering-14-3-3eta-testing-for-rheumatoid-arthritis"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mayo Clinic Laboratories adds 14-3-3eta serum testing to its diagnostic testing portfolio, expanding access to an important biomarker for rheumatoid arthritis VANCOUVER, British Columbia — Augurex Life Sciences Corp., a commercial-stage diagnostics company focused on autoimmune and inflammatory diseases, today announced that Mayo Clinic Laboratories is now offering 14-3-3eta serum testing for…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}